Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01449240 · ClinicalTrials.gov registry record
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A clinical trial, sponsored by Shire.
- Completed
- Registry status
- 10
- Enrollment target
NCT01449240 is a clinical trial that has completed, run by Shire. The registered enrollment target is 10 participants.
The verdict
NCT01449240 has completed, sponsored by Shire.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of the study is to collect data on CSF biomarkers in patients with Hunter Syndrome that would serve as reference data for comparison with cognitively impaired patients with Hunter syndrome, patients with other lysosomal storage diseases, or other diseases with CNS involvement.
Interventions
- OTHER No treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-11-12 |
| Est. Completion | 2013-12-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01449240
The ClinicalTrials.gov registry entry for NCT01449240 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No treatment is the first listed.
NCT01449240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01449240 about?
NCT01449240 is a clinical study titled "Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome". The purpose of the study is to collect data on CSF biomarkers in patients with Hunter Syndrome that would serve as reference data for comparison with cognitively impaired patients with Hunter syndrome, patients with other lysosomal storage diseases, or other diseases with CNS involvement.
What is the current status of trial NCT01449240?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2012-11-12. Estimated completion is 2013-12-20.
What interventions are being tested in trial NCT01449240?
The interventions under investigation include: No treatment (OTHER).
Who is sponsoring clinical trial NCT01449240?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.